RIBOPRO is an innovative and fast-growing mRNA specialist, providing premium (m)RNA technology, formulation and CDMO services to the pharmaceutical and biotechnology industry. RIBOPRO designs and synthesises high-performance mRNA for R&D and GMP purposes and delivers unconditional support from early research into clinical trials and commercialization.

Through their in-house research, the company continuously develops both the manufacturing processes for high quality mRNA and lipid nanoparticles (LNPs) and develops novel technologies to boost the performance of the mRNA/gain control over the delivery. These technologies not only provide better outcomes, but also provide freedom to operate in an otherwise competitive marketplace.